UK's Maxwellia Looking Into Daily Contraceptive Rx-To-OTC Switch

As calls for a non-prescription daily contraceptive pill grow in the UK, switch incubator Maxwellia suggests an Rx-to-OTC reclassification of the widely-used progestogen only pill may be one of its first "switch-in-a-box" projects. 

ContraceptivePill
• Source: Shutterstock

Responding to a growing demand in the UK for wider access to the daily contraceptive pill, England-based switch incubator Maxwellia is looking to switch the widely used progestogen only pill (POP) from prescription-only (POM) to pharmacy (P) status.

A new study has found that the increased availability and convenience of a non-prescription POP, along with rapid access to...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from United Kingdom

More from Europe